SCHEMBL743026

SCHEMBL743026

O=C(O)CCCCCCCCCCCCCCCCCO.OCC(CO)(CO)CO.OCC(CO)(CO)CO

nearest known ligand 0.76

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GPR84 Q9NQS5 8/20 0.76
FFAR1 O14842 2/20 0.76
FFAR4 Q5NUL3 2/20 0.76
CAMK2A Q9UQM7 1/20 0.59
TSHR P16473 5/20 0.57
LMNA P02545 3/20 0.57
NFKB1 P19838 1/20 0.57
PMP22 Q01453 1/20 0.57
FNTA P49354 1/20 0.47
FNTB P49356 1/20 0.47
PPARG P37231 6/20 0.46
PPARD Q03181 6/20 0.46
PPARA Q07869 6/20 0.46
HDAC11 Q96DB2 5/20 0.46
ALDH1A1 P00352 3/20 0.46
TLR2 O60603 2/20 0.46
TDP1 Q9NUW8 2/20 0.46
MEN1 O00255 2/20 0.46
FABP4 P15090 2/20 0.46
ALOX15 P16050 2/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Sebacic Acid SCHEMBL31652402 0.93 TSHR (0.67) GPR84FFAR1FFAR4CAMK2ATSHR
Sebacic Acid SCHEMBL9994017 0.93 TSHR (0.67) GPR84FFAR1FFAR4CAMK2ATSHR
Sebacic Acid SCHEMBL11491966 0.93 TSHR (0.67) GPR84FFAR1FFAR4CAMK2ATSHR
Azelaic Acid SCHEMBL9003214 0.93 TSHR (0.67) GPR84FFAR1FFAR4CAMK2ATSHR
Succinic Acid SCHEMBL193677 0.90 GPR84 (0.59) GPR84FFAR1FFAR4CAMK2ATSHR
Adipic Acid SCHEMBL28899127 0.90 LMNA (0.65) GPR84FFAR1FFAR4CAMK2ATSHR
Adipic Acid SCHEMBL722973 0.90 LMNA (0.65) GPR84FFAR1FFAR4CAMK2ATSHR
Adipic Acid SCHEMBL1906615 0.90 LMNA (0.65) GPR84FFAR1FFAR4CAMK2ATSHR
SCHEMBL8984680 0.87 GPR84 (1.00) GPR84FFAR1FFAR4CAMK2ATSHR
Sebacic Acid SCHEMBL11410575 0.87 GPR84 (1.00) GPR84FFAR1FFAR4CAMK2ATSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 19 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-119789840-A Composition, method and use for detoxifying hair and scalp 柯艾十八公司 2025-04-08 CN disclosed
CN-119744165-A Hair cleansing compositions, methods and uses thereof 柯艾十八公司 2025-04-01 CN disclosed
CN-112789027-B Oil-in-water type emulsified cosmetic 陶氏东丽株式会社 2023-11-07 CN disclosed
CN-112689500-B Oil-in-water type emulsified cosmetic 陶氏东丽株式会社 2023-09-12 CN disclosed
CN-112789022-B Oil-in-water type emulsified cosmetic 陶氏东丽株式会社 2023-08-25 CN disclosed
CN-112804988-B Cosmetic material 陶氏东丽株式会社 2023-07-18 CN disclosed
CN-111372551-B Gel sheet for skin adhesion 株式会社高丝 2023-07-04 CN disclosed
CN-114727937-B Skin cleanser 花王株式会社 2023-06-16 CN disclosed
CN-115884752-A Compositions, methods and uses for hair follicle modulation 米尼翁大学 2023-03-31 CN disclosed
CN-112351768-A Composition for skin cosmetic 株式会社漫丹 2021-02-09 CN disclosed
CN-105916487-B Peptide compositions and uses thereof 米尼翁大学 2020-03-24 CN disclosed
EP-2431022-B1 Composition based on a cross-linked fluorine-containing silicone for a cosmetic composition SHINETSU CHEMICAL CO (JP) 2017-02-22 EP disclosed
US-9364420-B2 Hair conditioning compositions KAO USA INC. (US) 2016-06-14 US disclosed
EP-2948127-A2 HAIR AND SKIN CONDITIONING COMPOSITIONS Kao Corporation (JP) 2015-12-02 EP disclosed
WO-2014114975-A2 HAIR AND SKIN CONDITIONING COMPOSITIONS KAO CORPORATION (JP) 2014-07-31 WO disclosed
US-8574557-B2 Composition for a cosmetic and a cosmetic comprising the same SHIN-ETSU CHEMICAL CO., LTD. (JP) 2013-11-05 US disclosed
US-20130164240-A1 HAIR CONDITIONING COMPOSITIONS KAO CORPORATION (JP) 2013-06-27 US disclosed
EP-2431022-A2 Composition based on a cross-linked fluorine-containing silicone for a cosmetic composition Shin-Etsu Chemical Co., Ltd. (JP) 2012-03-21 EP disclosed
US-20110217250-A1 COMPOSITION FOR A COSMETIC AND A COSMETIC COMPRISING THE SAME SHIN-ETSU CHEMICAL CO., LTD. (JP) 2011-09-08 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110217250-A1 COMPOSITION FOR A COSMETIC AND A COSMETIC COMPRISING THE SAME FUCA1, F7, F12 GPR84 1605/4885FFAR1 208/4885FFAR4 627/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.